The threat of antimicrobial resistance AMR is real. It is no longer just an infectious disease challenge as it is becoming a major threat to #cancer care. Protecting patients against rising AMR threats will require investment in new antibiotics, smarter policies, and sustained innovation so that life-saving treatments remain effective the way they are intended to be.
https://t.co/rKvr0bqrwT